Jill Marie Broadfoot - 04 Jun 2025 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Jill Marie Broadfoot by Colin Sandercock, attorney-in-fact
Issuer symbol
CUE
Transactions as of
04 Jun 2025
Net transactions value
$0
Form type
3
Filing time
06 Jun 2025, 16:00:04 UTC
Previous filing
04 Feb 2025
Next filing
24 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Broadfoot Jill Marie Director C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON /s/ Jill Marie Broadfoot by Colin Sandercock, attorney-in-fact 06 Jun 2025 0001305178

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney